Skip to main navigation Skip to search Skip to main content

The Do stAtins faVourably modify atherosclerotIc plaque in patients with differeNt levels of polygenic Cardiovascular rIsk? (DA VINCI) trial

  • Nelson, Adam (Primary Chief Investigator (PCI))

Project: Research

Project Details

Short titleUsing a patient's genetic code to identify those likely to benefit from preventive statin therapy
StatusFinished
Effective start/end date1/01/22 → 31/12/24

Funding

  • National Heart Foundation of Australia: A$110,720.00

Clinical Trial Phase

  • Phase II
  • Phase III (a & b)
  • Sponsor is Monash University